Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Yellow Fever Vaccine Immunity Paraiba Study
NCT02555072Phase 4Active, not recruiting
- Sponsor
- Immunobiological Technology Institute
- Start
- Jul 2016
- Primary completion
- Jun 2026
- Modality
- Live Attenuated Vaccines
- Countries
- 1
01
Overview
A Phase 4 trial of 17D yellow fever vaccine in yellow fever, sponsored by Immunobiological Technology Institute. Started Jul 2016; status: active, not recruiting.
02
Drugs
17D yellow fever vaccine
03
Conditions
yellow fever
Beyond the preview
Go deeper on NCT02555072.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02555072.